These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28660485)

  • 1. CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.
    Moutal A; Villa LS; Yeon SK; Householder KT; Park KD; Sirianni RW; Khanna R
    Mol Neurobiol; 2018 May; 55(5):4403-4416. PubMed ID: 28660485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Ubc9-Induced CRMP2 SUMOylation Disrupts Glioblastoma Cell Proliferation.
    Wang L; Ji S
    J Mol Neurosci; 2019 Nov; 69(3):391-398. PubMed ID: 31267313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
    Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
    Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.
    Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R
    Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRMP2-Neurofibromin Interface Drives NF1-related Pain.
    Moutal A; Sun L; Yang X; Li W; Cai S; Luo S; Khanna R
    Neuroscience; 2018 Jun; 381():79-90. PubMed ID: 29655575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
    Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
    J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide.
    Moutal A; Yang X; Li W; Gilbraith KB; Luo S; Cai S; François-Moutal L; Chew LA; Yeon SK; Bellampalli SS; Qu C; Xie JY; Ibrahim MM; Khanna M; Park KD; Porreca F; Khanna R
    Pain; 2017 Dec; 158(12):2301-2319. PubMed ID: 28809766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.
    Yu J; Moutal A; Dorame A; Bellampalli SS; Chefdeville A; Kanazawa I; Pham NYN; Park KD; Weimer JM; Khanna R
    Mol Neurobiol; 2019 Jul; 56(7):5241-5255. PubMed ID: 30565051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
    Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
    Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
    Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
    Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness.
    Fadhlullah SFB; Halim NBA; Yeo JYT; Ho RLY; Um P; Ang BT; Tang C; Ng WH; Virshup DM; Ho IAW
    Oncogene; 2019 Jul; 38(27):5367-5380. PubMed ID: 30967630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
    Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
    Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyr3 Induces Apoptosis and Inhibits Migration in Human Glioblastoma Cells.
    Chang HH; Cheng YC; Tsai WC; Tsao MJ; Chen Y
    Cell Physiol Biochem; 2018; 48(4):1694-1702. PubMed ID: 30078005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.
    Hensley K; Venkova K; Christov A; Gunning W; Park J
    Mol Neurobiol; 2011 Jun; 43(3):180-91. PubMed ID: 21271304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration.
    Varrin-Doyer M; Vincent P; Cavagna S; Auvergnon N; Noraz N; Rogemond V; Honnorat J; Moradi-Améli M; Giraudon P
    J Biol Chem; 2009 May; 284(19):13265-76. PubMed ID: 19276087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.